Latest Insider Transactions at Ptc Therapeutics, Inc. (PTCT)
This section provides a real-time view of insider transactions for Ptc Therapeutics, Inc. (PTCT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PTC THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PTC THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 07
2022
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
BUY
Grant, award, or other acquisition
|
Indirect |
780
+23.85%
|
-
|
|
Jan 07
2022
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect |
45
-2.56%
|
$1,710
$38.52 P/Share
|
|
Jan 07
2022
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
14,400
+22.55%
|
-
|
|
Jan 07
2022
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Direct |
756
-2.11%
|
$28,728
$38.52 P/Share
|
|
Jan 07
2022
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
11,600
+29.4%
|
-
|
|
Jan 07
2022
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
747
-4.39%
|
$28,386
$38.52 P/Share
|
|
Jan 04
2022
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
378
-1.63%
|
$15,498
$41.16 P/Share
|
|
Jan 04
2022
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
806
-2.23%
|
$33,046
$41.16 P/Share
|
|
Jan 04
2022
|
Emily Luisa Hill CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
173
-0.74%
|
$7,093
$41.16 P/Share
|
|
Jan 04
2022
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect |
64
-3.52%
|
$2,624
$41.16 P/Share
|
|
Sep 02
2021
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
3,363
-6.5%
|
$151,335
$45.01 P/Share
|
|
Sep 02
2021
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,363
+6.1%
|
$60,534
$18.01 P/Share
|
|
Aug 13
2021
|
Stephanie Okey |
SELL
Open market or private sale
|
Direct |
1,650
-63.15%
|
$66,000
$40.06 P/Share
|
|
Jul 09
2021
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
1,429
-0.73%
|
$64,305
$45.0 P/Share
|
|
Jul 09
2021
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,429
+0.73%
|
$25,722
$18.01 P/Share
|
|
Jul 08
2021
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
7,805
-2.62%
|
$351,225
$45.23 P/Share
|
|
Jul 08
2021
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,805
+2.55%
|
$117,075
$15.75 P/Share
|
|
Jun 11
2021
|
Mary L. Smith |
BUY
Grant, award, or other acquisition
|
Direct |
2,613
+38.46%
|
-
|
|
Jun 11
2021
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Indirect |
6,240
+21.55%
|
-
|
|
Jun 09
2021
|
Dawn Svoronos |
SELL
Open market or private sale
|
Direct |
365
-1.33%
|
$14,965
$41.88 P/Share
|
|
Apr 20
2021
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,641
-4.49%
|
$77,127
$47.25 P/Share
|
|
Apr 19
2021
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
859
-4.45%
|
$41,232
$48.17 P/Share
|
|
Apr 19
2021
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
786
-2.15%
|
$37,728
$48.17 P/Share
|
|
Apr 13
2021
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Indirect |
1,400
+7.83%
|
-
|
|
Feb 08
2021
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
2,657
-13.86%
|
$175,362
$66.0 P/Share
|
|
Feb 08
2021
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,657
+12.18%
|
$87,681
$33.02 P/Share
|
|
Feb 02
2021
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
652
-3.8%
|
$37,164
$57.64 P/Share
|
|
Feb 01
2021
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
368
-2.1%
|
$20,608
$56.96 P/Share
|
|
Feb 01
2021
|
Dawn Svoronos |
SELL
Open market or private sale
|
Direct |
506
-1.81%
|
$28,336
$56.96 P/Share
|
|
Feb 01
2021
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
283
-1.84%
|
$15,848
$56.96 P/Share
|
|
Feb 01
2021
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,968
-2.39%
|
$110,208
$56.96 P/Share
|
|
Feb 01
2021
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
362
-0.98%
|
$20,272
$56.96 P/Share
|
|
Feb 01
2021
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect |
28
-1.52%
|
$1,568
$56.96 P/Share
|
|
Feb 01
2021
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Direct |
973
-2.65%
|
$54,488
$56.96 P/Share
|
|
Feb 01
2021
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
778
-1.58%
|
$43,568
$56.96 P/Share
|
|
Feb 01
2021
|
Emily Luisa Hill CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
541
-2.27%
|
$30,296
$56.96 P/Share
|
|
Jan 25
2021
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
350
-2.23%
|
$21,700
$62.05 P/Share
|
|
Jan 25
2021
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
431
-1.16%
|
$26,722
$62.05 P/Share
|
|
Jan 25
2021
|
Emily Luisa Hill CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
275
-1.14%
|
$17,050
$62.05 P/Share
|
|
Jan 25
2021
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect |
541
-11.57%
|
$33,542
$62.65 P/Share
|
|
Jan 15
2021
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
4,300
-18.21%
|
$296,700
$69.09 P/Share
|
|
Jan 15
2021
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,300
+15.41%
|
$163,400
$38.98 P/Share
|
|
Jan 13
2021
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
3,947
-6.8%
|
$260,502
$66.57 P/Share
|
|
Jan 13
2021
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,288
+7.61%
|
$46,032
$14.62 P/Share
|
|
Jan 08
2021
|
Emily Luisa Hill CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
26,033
-20.24%
|
$1,796,277
$69.75 P/Share
|
|
Jan 08
2021
|
Emily Luisa Hill CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
26,033
+16.36%
|
$598,759
$23.28 P/Share
|
|
Jan 08
2021
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,500
-11.67%
|
$379,500
$69.9 P/Share
|
|
Jan 08
2021
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+18.15%
|
$209,000
$38.98 P/Share
|
|
Jan 08
2021
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect |
1,300
-35.25%
|
$89,700
$69.0 P/Share
|
|
Jan 08
2021
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,300
+26.06%
|
$35,100
$27.05 P/Share
|